Molecular epidemiology and antimicrobial resistance of group a streptococcus recovered from patients in Beijing, China

Abstract Background Group A streptococcus (GAS) is an important human pathogen responsible for a broad range of infections. Epidemiological surveillance has been crucial to detect changes in the geographical and temporal variation of the disease pattern. The objective of this study was to investigat...

Full description

Bibliographic Details
Main Authors: Hongxin Li, Lin Zhou, Yong Zhao, Lijuan Ma, Xiaoyan Liu, Jin Hu
Format: Article
Language:English
Published: BMC 2020-07-01
Series:BMC Infectious Diseases
Subjects:
GAS
Online Access:http://link.springer.com/article/10.1186/s12879-020-05241-x
id doaj-331b86c58d714941a0bc212023e559df
record_format Article
spelling doaj-331b86c58d714941a0bc212023e559df2020-11-25T03:43:25ZengBMCBMC Infectious Diseases1471-23342020-07-012011910.1186/s12879-020-05241-xMolecular epidemiology and antimicrobial resistance of group a streptococcus recovered from patients in Beijing, ChinaHongxin Li0Lin Zhou1Yong Zhao2Lijuan Ma3Xiaoyan Liu4Jin Hu5Department of Dermatology, Children’s Hospital Affiliated to Capital Institute of PediatricsDepartment of Clinical Laboratory, Children’s Hospital Affiliated to Capital Institute of PediatricsThe Sixth Medical Centre of PLADepartment of Clinical Laboratory, Children’s Hospital Affiliated to Capital Institute of PediatricsDepartment of Dermatology, Children’s Hospital Affiliated to Capital Institute of PediatricsDepartment of Dermatology, Children’s Hospital Affiliated to Capital Institute of PediatricsAbstract Background Group A streptococcus (GAS) is an important human pathogen responsible for a broad range of infections. Epidemiological surveillance has been crucial to detect changes in the geographical and temporal variation of the disease pattern. The objective of this study was to investigate the molecular epidemiological characteristics and antimicrobial resistance of GAS isolates from patients in Children’s Hospital in Beijing. Methods From 2016 to 2017, pharyngeal swab samples were collected from the outpatients in Children’s Hospital, Capital Institute of Pediatrics, who were diagnosed with scarlet fever. Antimicrobial susceptibility test was performed according to the distribution of conventional antibiotics and Clinical and Laboratory Standards Institute (CLSI) recommendations. The distribution of the macrolide-resistance genes (ermB, ermA, mefA), emm (M protein-coding gene) typing, and superantigens (SAg) gene profiling were examined by polymerase chain reaction (PCR). Results A total of 297 GAS isolates were collected. The susceptibility of the isolates to penicillin, ceftriaxone, and levofloxacin was 100%. The resistance rate to erythromycin and clindamycin was 98.3 and 96.6%, respectively. The dominant emm types were emm12 (65.32%), emm1 (27.61%), emm75 (2.69%), and emm89 (1.35%). Of the 297 isolates, 290 (97.64%) carried the ermB gene, and 5 (1.68%) carried the mefA gene, while none carried the ermA gene. The most common superantigen genes identified from GAS isolates were smeZ (96.97%), speC (92.59%), speG (91.58%), ssa (85.52%), speI (54.55%), speH (52.19%), and speA (34.34%). Isolates with the genotype emm1 possessed speA, speC, speG, speJ, speM, ssa, and smeZ, while emm12 possessed speC, speG, speH, speI, speM, ssa, and smeZ superantigens. Conclusions The prevalent strain of GAS isolates in Beijing has a high resistance rate to macrolides; however, penicillin can still be the preferred antibiotic for treatment. Erythromycin resistance was predominantly mediated by ermB. The common emm types were emm12 and emm1. There was a correlation between emm and the superantigen gene. Thus, long-term monitoring and investigation of the emm types and superantigen genes of GAS prevalence are imperative.http://link.springer.com/article/10.1186/s12879-020-05241-xGroup a streptococcusGASStreptococcal M proteinemm typesSuperantigensAntimicrobial resistance
collection DOAJ
language English
format Article
sources DOAJ
author Hongxin Li
Lin Zhou
Yong Zhao
Lijuan Ma
Xiaoyan Liu
Jin Hu
spellingShingle Hongxin Li
Lin Zhou
Yong Zhao
Lijuan Ma
Xiaoyan Liu
Jin Hu
Molecular epidemiology and antimicrobial resistance of group a streptococcus recovered from patients in Beijing, China
BMC Infectious Diseases
Group a streptococcus
GAS
Streptococcal M protein
emm types
Superantigens
Antimicrobial resistance
author_facet Hongxin Li
Lin Zhou
Yong Zhao
Lijuan Ma
Xiaoyan Liu
Jin Hu
author_sort Hongxin Li
title Molecular epidemiology and antimicrobial resistance of group a streptococcus recovered from patients in Beijing, China
title_short Molecular epidemiology and antimicrobial resistance of group a streptococcus recovered from patients in Beijing, China
title_full Molecular epidemiology and antimicrobial resistance of group a streptococcus recovered from patients in Beijing, China
title_fullStr Molecular epidemiology and antimicrobial resistance of group a streptococcus recovered from patients in Beijing, China
title_full_unstemmed Molecular epidemiology and antimicrobial resistance of group a streptococcus recovered from patients in Beijing, China
title_sort molecular epidemiology and antimicrobial resistance of group a streptococcus recovered from patients in beijing, china
publisher BMC
series BMC Infectious Diseases
issn 1471-2334
publishDate 2020-07-01
description Abstract Background Group A streptococcus (GAS) is an important human pathogen responsible for a broad range of infections. Epidemiological surveillance has been crucial to detect changes in the geographical and temporal variation of the disease pattern. The objective of this study was to investigate the molecular epidemiological characteristics and antimicrobial resistance of GAS isolates from patients in Children’s Hospital in Beijing. Methods From 2016 to 2017, pharyngeal swab samples were collected from the outpatients in Children’s Hospital, Capital Institute of Pediatrics, who were diagnosed with scarlet fever. Antimicrobial susceptibility test was performed according to the distribution of conventional antibiotics and Clinical and Laboratory Standards Institute (CLSI) recommendations. The distribution of the macrolide-resistance genes (ermB, ermA, mefA), emm (M protein-coding gene) typing, and superantigens (SAg) gene profiling were examined by polymerase chain reaction (PCR). Results A total of 297 GAS isolates were collected. The susceptibility of the isolates to penicillin, ceftriaxone, and levofloxacin was 100%. The resistance rate to erythromycin and clindamycin was 98.3 and 96.6%, respectively. The dominant emm types were emm12 (65.32%), emm1 (27.61%), emm75 (2.69%), and emm89 (1.35%). Of the 297 isolates, 290 (97.64%) carried the ermB gene, and 5 (1.68%) carried the mefA gene, while none carried the ermA gene. The most common superantigen genes identified from GAS isolates were smeZ (96.97%), speC (92.59%), speG (91.58%), ssa (85.52%), speI (54.55%), speH (52.19%), and speA (34.34%). Isolates with the genotype emm1 possessed speA, speC, speG, speJ, speM, ssa, and smeZ, while emm12 possessed speC, speG, speH, speI, speM, ssa, and smeZ superantigens. Conclusions The prevalent strain of GAS isolates in Beijing has a high resistance rate to macrolides; however, penicillin can still be the preferred antibiotic for treatment. Erythromycin resistance was predominantly mediated by ermB. The common emm types were emm12 and emm1. There was a correlation between emm and the superantigen gene. Thus, long-term monitoring and investigation of the emm types and superantigen genes of GAS prevalence are imperative.
topic Group a streptococcus
GAS
Streptococcal M protein
emm types
Superantigens
Antimicrobial resistance
url http://link.springer.com/article/10.1186/s12879-020-05241-x
work_keys_str_mv AT hongxinli molecularepidemiologyandantimicrobialresistanceofgroupastreptococcusrecoveredfrompatientsinbeijingchina
AT linzhou molecularepidemiologyandantimicrobialresistanceofgroupastreptococcusrecoveredfrompatientsinbeijingchina
AT yongzhao molecularepidemiologyandantimicrobialresistanceofgroupastreptococcusrecoveredfrompatientsinbeijingchina
AT lijuanma molecularepidemiologyandantimicrobialresistanceofgroupastreptococcusrecoveredfrompatientsinbeijingchina
AT xiaoyanliu molecularepidemiologyandantimicrobialresistanceofgroupastreptococcusrecoveredfrompatientsinbeijingchina
AT jinhu molecularepidemiologyandantimicrobialresistanceofgroupastreptococcusrecoveredfrompatientsinbeijingchina
_version_ 1724520127026692096